Healthcare

American Association for Cancer Research Annual Meeting 2025: Stay Ahead with Real-Time AACR Conference Coverage and Expert Analysis from DelveInsight

LAS VEGAS, Feb. 10, 2025, 17:31 GMT-05

DELVEINSIGHT

Read full article →

Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis

HERZLIYA, Israel and CALGARY, AB, Feb. 10, 2025, 16:00 GMT-05

Innocan-Osteoarthriti

Read full article →

Pen Needles Market to Hit USD 3.08 Billion by 2030 with 9.2% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Feb. 10, 2025, 10:30 GMT-05

MARKETSANDMARKETS

Read full article →

AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Celiac Disease (CD) multiplex microarray

EYSINS, Switzerland, Feb. 10, 2025, 05:00 GMT-05

AliveDx-MosaiQ-AiPlex

Read full article →

ANTARES VISION GROUP SIGNS LANDMARK AGREEMENT WITH THE MINISTRY OF HEALTH OF GUINEA-BISSAU

BRESCIA, Italy, Feb. 10, 2025, 05:00 GMT-05

Antares-Vision-Group

Read full article →

BioRay's ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA

SHANGHAI, Feb. 10, 2025, 02:40 GMT-05

BioRay-ClinicalTrial

Read full article →

Daewoong Pharmaceutical, a leading healthcare company in Korea, has launched its botulinum toxin product NABOTA in Saudi Arabia

SEOUL, South Korea and RIYADH, Saudi Arabia, Feb. 10, 2025, 00:41 GMT-05

Daewoong

Read full article →

2025 Singclean Global Aesthetic Master Symposium Debuted in France

PARIS, Feb. 10, 2025, 23:03 GMT-05

HANGZHOU-SINGCLEAN-UK

Read full article →

Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis

CHENGDU, China, Feb. 8, 2025, 20:50 GMT-05

Keymed-Biosciences

Read full article →

AI Revolutionizing Industries: Market Set for 39.7% CAGR Growth, Reaching $1.1 Trillion by 2029

BOSTON, Feb. 7, 2025, 10:32 GMT-05

BCCRESEARCHLLC

Read full article →

Water Treatment Chemicals Market worth $46.64 billion by 2029 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Feb. 7, 2025, 06:55 GMT-05

MARKETSANDMARKETS

Read full article →

Dedicare's Year-end Report 1 January - 31 December 2024: Continued weak progress in the fourth quarter concluded a challenging 2024

STOCKHOLM, Feb. 7, 2025, 02:33 GMT-05

DEDICARE-earnings

Read full article →

Q4 and Year-end Report 2024 Sweco AB (publ)

STOCKHOLM, Feb. 7, 2025, 01:36 GMT-05

SWECO-Q4-2024-ERN

Read full article →

Global Airway Clearance Devices for Cystic Fibrosis Market to Show Positive Growth at a CAGR of ~5% by 2032 | DelveInsight

LAS VEGAS, Feb. 6, 2025, 17:31 GMT-05

DelveInsight-Business

Read full article →

Corti's First AId Report: Burnout levels challenge healthcare professionals' ability to care for patients in Europe and the U.S.

NEW YORK, Feb. 6, 2025, 09:24 GMT-05

Corti

Read full article →

Stax Appoints Adam Thorpe as Managing Director to Lead EMEA Healthcare Vertical and Drive Expansion in UK and European Markets

NEW YORK, Feb. 6, 2025, 05:02 GMT-05

Stax-LLC-personnel-EU

Read full article →

Cynerio Ranked Among Top 2 Vendors in 2025 Best in KLAS in Healthcare IoT Security

NEW YORK, Feb. 6, 2025, 04:00 GMT-05

CynerioKLASHealthcare

Read full article →

Accord Healthcare: Hetronifly® (Serplulimab) receives Marketing Authorisation from the European Commission (EC), for the treatment of Extensive-Stage Small Cell Lung Cancer (ES- SCLC)

LONDON, Feb. 6, 2025, 03:30 GMT-05

Accord-Healthcare

Read full article →

U.S. FDA Grants Orphan Drug Designation to Ariceum Therapeutics' Proprietary Radiopharmaceutical Cancer Therapy

BERLIN, Feb. 6, 2025, 03:30 GMT-05

Ariceum-Therapeutics

Read full article →

Implantica announces onboarding of the world-leading La Paz University Hospital, Spain

VADUZ, Liechtenstein, Feb. 6, 2025, 02:58 GMT-05

IMPLANTICA-Hospital

Read full article →